Dexmedetomidine and contrast induced nephropathy in patients undergoing coronary angiography using non-ionic contrast media.

Dexmedetomidine and contrast induced nephropathy in patients undergoing coronary angiography using non-ionic contrast media. - Dexmedetomidine and contrast induced nephropathy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030258

Enrollment

Registered

2017-12-04

Start date

2017-11-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients undergoing coronary angiography using non-ionic contrast media were recruited into the study

Interventions

In group D, a loading dose of 0.001mg/kg dexmedetomidine given over 10 min followed by 0.0005mg/kg/h dexmedetomidine infusion. In group S, patients recived the same amount of saline 0.9% infusion.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: adult patients undergoing coronary angiography were included in this study.

Exclusion criteria

Exclusion criteria: 1,emergency cases; 2,patients with renal failure or diabetes mellitus, patients who were on nephrotoxic and vasoactive drugs simultaneously and patients with decompensated congestive heart failure; 3,patients who had been administered contrast media in the last 2 weeks;

Design outcomes

Primary

Measure	Time frame
the overall incidence of contrast induced nephropathy	—

Countries

Asia(except Japan)

Contacts

Public ContactChen jie

Third Military Medical University Department of Anaesthesiology, Southwest Hospital,

cjandsh@tmmu.edu..cn+81-086-23-68754197

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026